Persistence With Biologic Therapy and Associated Costs of Patients With Inflammatory Bowel Disease: A German Retrospective Claims Data Analysis

BACKGROUND: In recent years, biologic agents became a relevant and promising treatment option for inflammatory bowel diseases (IBDs). However, high treatment costs and moderate remission rates lead to a high interest in treatment persistence and corresponding economic consequences. METHODS: A retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahlich, Joerg, May, Melanie, Feig, Chiara, Straub, Vincent, Schmelz, Renate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802337/
https://www.ncbi.nlm.nih.gov/pubmed/36778945
http://dx.doi.org/10.1093/crocol/otab011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802337/
https://www.ncbi.nlm.nih.gov/pubmed/36778945
http://dx.doi.org/10.1093/crocol/otab011

Ejemplares similares